Brainstorm Cell Therapeutics Inc Share Price OTC Bulletin Board
Equities
US10501E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
17/04 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
17/04 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.22M 2.27B |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.75B | Net income 2025 * | -27M -2.25B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.42
x | P/E ratio 2025 * |
-1.06
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.72% |
Latest transcript on Brainstorm Cell Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/01 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/23 |
Chief Tech/Sci/R&D Officer | - | 12/22/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/00/22 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/14/06 |
Jacob Frenkel
CHM | Chairman | 81 | 30/20/30 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |